NEW YORK (GenomeWeb News) – Swedish firms AlphaHelix Molecular Diagnostics and Techtum Lab have merged in an all-stock deal.
Under the terms of the deal, AlphaHelix will issue about 29.4 million shares of its stock at a price of SEK6.8 million ($1 million) to Labkompaniet, which owned Techtum. After the deal is completed, Labkompaniet will own a little less than 64 percent of the new company and shareholders of AlphaHelix will own the balance.
In a statement, AlphaHelix said that the deal provides it with a "complete marketing and sales organization" built upon 20 years of selling qPCR products in Scandinavia.
Techtum Lab sells PCR instruments and consumables. AlphaHelix develops and markets qPCR instruments.